Showing posts with label ledispasvir. Show all posts
Showing posts with label ledispasvir. Show all posts

Monday, July 27, 2015

Cure For Hepatitis C

The last disease that the criminal medical industry cured was polio and polio was not cured cured by the medical industry as we know it. Jonas Salk created the polio vaccine and unlike today's vaccines it was safe and effective. 

The cure for Hepatitis C is a drug concoction called Harvoni. I was shocked when I saw the commercials that the criminal medical industry has actually released a cure for a major disease. Normally the medical industry slime will exploit/manage a disease for a steady stream of obscene profits from their suffering paitients/medical consumers who they regard as cash vending machines. I thought that perhaps that maybe someone in the pharmaceutical industry actually developed a conscience but that would be a miracle. The I thought that maybe some of the big pharma slime was being blackmailed or threatened into do the moral thing but I was wrong. 

Harvoni is a blend of two existing anti viral drugs. It contains 90 mg of ledispasvir and 400 mg of sofosbuvir, The clinical trials showed a 96% cure rate. That may or may not be true. Big pharma tells a lot of lies. 

The treatment regime that leads to a cure is 12 to 24 weeks of daily Harvoni pills.

Gilead Sciences the criminals who sell Harvoni charge $1,125 per pill, or $94,500for a 12-weeks of treatment Other new medications are nearly as pricey. Insurers are scrambling to figure out how to 
pay for treatment without breaking the bank. Many say they will only cover costly therapies for the 
sickest patients.

The scum at Gilead justify their cruel price gouging by saying that $94,500 to $189,000 costs less than a liver transplant. 

Related: In March 2015, Gilead Sciences e-mailed warnings to health care providers about nine patients that began taking its hepatitis C drugs Harvoni (ledipasvir/sofosbuvir) or Sovaldi (sofosbuvir) along with the heart treatments amiodaroneBristol-Myers Squibb'sdaclatasvir, or Johnson & Johnson's simeprevir developed abnormally slow heartbeats and one died of cardiac arrest. Three required a pacemaker to be inserted. Gilead said the combinations aren't recommended and product labels will be updated


Related: Will competition push down the high prices that make Hepatitis C drugs too expensive for some patients? CLICK HERE